OBSERVATIONAL INSIGHTS INTO THE PREVALENCE, ETIOLOGY, RISK FACTORS, CLINICAL FEATURES, DIAGNOSIS, OUTCOMES AND MANAGEMENT OF OLIGOHYDRAMNIOS IN GESTATIONAL WOMEN

Oligohydramnios is a condition characterized by decreased amniotic fluid volume in gestational women, often associated with complications such as intrauterine growth restriction, premature rupture of membranes, and fetal distress. This study aims to evaluate the prevalence, etiology, risk factors, and management of oligohydramnios in a tertiary care setting. A total of 120 pregnant women diagnosed with oligohydramnios were included in the study. Data on age, gestational age, symptoms, medical history, and pregnancy outcomes were collected. Findings revealed that 27.5% of cases occurred in women aged 22-25 years, with the majority diagnosed between 30-32 weeks of gestation. Common risk factors included hypertension (12.6%), hypothyroidism (16.6%), and inadequate fluid intake (34.2%). Complications such as miscarriage (19.19%) and premature birth (6.66%) were observed. The study underscores the importance of early detection, adequate hydration, and lifestyle modifications to improve pregnancy outcomes. Healthcare professionals, including clinical pharmacists, should play an active role in educating pregnant women on risk factors and preventive strategies.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-28
DOI
https://doi.org/10.5281/zenodo.15100568
Primary Topic
Preterm Birth and Chorioamnionitis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

OBSERVATIONAL INSIGHTS INTO THE PREVALENCE, ETIOLOGY, RISK FACTORS, CLINICAL FEATURES, DIAGNOSIS, OUTCOMES AND MANAGEMENT OF OLIGOHYDRAMNIOS IN GESTATIONAL WOMEN

Zenodo (CERN European Organization for Nuclear Research)
Preterm Birth and Chorioamnionitis
article

OBSERVATIONAL INSIGHTS INTO THE PREVALENCE, ETIOLOGY, RISK FACTORS, CLINICAL FEATURES, DIAGNOSIS, OUTCOMES AND MANAGEMENT OF OLIGOHYDRAMNIOS IN GESTATIONAL WOMEN

article en

Abstract

Oligohydramnios is a condition characterized by decreased amniotic fluid volume in gestational women, often associated with complications such as intrauterine growth restriction, premature rupture of membranes, and fetal distress. This study aims to evaluate the prevalence, etiology, risk factors, and management of oligohydramnios in a tertiary care setting. A total of 120 pregnant women diagnosed with oligohydramnios were included in the study. Data on age, gestational age, symptoms, medical history, and pregnancy outcomes were collected. Findings revealed that 27.5% of cases occurred in women aged 22-25 years, with the majority diagnosed between 30-32 weeks of gestation. Common risk factors included hypertension (12.6%), hypothyroidism (16.6%), and inadequate fluid intake (34.2%). Complications such as miscarriage (19.19%) and premature birth (6.66%) were observed. The study underscores the importance of early detection, adequate hydration, and lifestyle modifications to improve pregnancy outcomes. Healthcare professionals, including clinical pharmacists, should play an active role in educating pregnant women on risk factors and preventive strategies.

Zenodo (CERN European Organization for Nuclear Research)
Sri Venkateswara Institute of Medical Sciences (IN)
Openalex Percentile: Top 45%
Preterm Birth and Chorioamnionitis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

OBSERVATIONAL INSIGHTS INTO THE PREVALENCE, ETIOLOGY, RISK FACTORS, CLINICAL FEATURES, DIAGNOSIS, OUTCOMES AND MANAGEMENT OF OLIGOHYDRAMNIOS IN GESTATIONAL WOMEN · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS